BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9758904)

  • 1. Whole-blood flow-cytometric analysis of eosinophil EG2 expression as a marker of the pathological conditions of asthma.
    Kuwasaki T; Chihara J; Kayaba H; Kamata Y; Oyamada H; Saito N; Shioya T; Sasaki M; Kagaya M; Tsuda A
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():77-80. PubMed ID: 9758904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A flow cytometric method for the detection of intracellular basic proteins in unseparated peripheral blood and bone marrow eosinophils.
    Krug N; Thurau AM; Lackie P; Baier J; Schultze-Werninghaus G; Rieger CH; Schauer U
    J Immunol Methods; 1996 Apr; 190(2):245-54. PubMed ID: 8621959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EG2 expressed by eosinophils as a clinically useful indicator of asthma.
    Kamada Y; Kayaba H; Ito W; Ueki S; Kobayashi Y; Yamada Y; Saito N; Takahashi T; Oyamada H; Chihara J
    Allergy Asthma Proc; 2008; 29(6):609-13. PubMed ID: 19173787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of blood EG2+ eosinophils in patients with bronchial asthma.
    Monteseirín J; Llamas E; Muñoz F; Bono MJ; Conde J
    Allergol Immunopathol (Madr); 1993; 21(3):97-9. PubMed ID: 8356938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tests for bronchial asthma].
    Adachi T; Chihara J
    Rinsho Byori; 2000 Dec; 48(12):1125-9. PubMed ID: 11215421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The changes of EG1 and EG2 positive eosinophils and their clinical significance in asthmatics].
    Huang H; Xu J; Zhong N
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):612-4. PubMed ID: 11477881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course.
    Skedinger M; Halldén G; Lundahl J; Hed J; Zetterström O
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):250-5. PubMed ID: 7552927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils.
    Jahnsen FL; Brandtzaeg P; Halstensen TS
    J Immunol Methods; 1994 Sep; 175(1):23-36. PubMed ID: 7930638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma.
    Moqbel R; Barkans J; Bradley BL; Durham SR; Kay AB
    Clin Exp Allergy; 1992 Feb; 22(2):265-73. PubMed ID: 1373987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The degree of natural allergen exposure modifies eosinophil activity markers in the circulation of patients with mild asthma.
    Fernvik E; Grönneberg R; Lundahl J; Hed J; Andersson O; Johansson SG; Halldén G
    Allergy; 1996 Oct; 51(10):697-705. PubMed ID: 8904997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemically stained activated eosinophils in sputum in patients with asthma.
    Jang AS; Choi IS; Park CS
    Respiration; 2000; 67(2):183-8. PubMed ID: 10773791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counts of activated blood eosinophils for monitoring asthma.
    Hed J; Halldén G
    Allergy; 1993; 48(17 Suppl):87-93; discussion 110-1. PubMed ID: 8109719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with psoriasis have elevated levels of serum eosinophil cationic protein and increased numbers of EG2 positive eosinophils in the duodenal stroma.
    Michaëlsson G; Kraaz W; Gerdén B; Hagforsen E; Lundin IP; Lööf L; Sj-oberg O; Scheynius A
    Br J Dermatol; 1996 Sep; 135(3):371-8. PubMed ID: 8949428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditions in blood sampling procedures that extend the ex vivo stability of eosinophil activity markers in peripheral blood from allergic patients and healthy controls.
    Halldén G; Nopp A; Ihre E; Peterson C; Lundahl J
    Ann Allergy Asthma Immunol; 1999 Nov; 83(5):413-21. PubMed ID: 10582722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prednisolone on eosinophils, IL-5, eosinophil cationic protein, EG2+ eosinophils, and nitric oxide metabolites in the sputum of patients with exacerbated asthma.
    Jang AS; Choi IS; Koh YI; Jeong TK; Lee KY; Kim YS; Lee JU; Park CS
    J Korean Med Sci; 2000 Oct; 15(5):521-8. PubMed ID: 11068988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of activated eosinophils, high IgE and sCD23 titers in gingival crevicular fluid of patients with adult periodontitis.
    Suzuki T; Sugita N; Yoshie H; Hara K
    J Periodontal Res; 1995 May; 30(3):159-66. PubMed ID: 7472997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
    Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
    Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Eosinophil activation evaluated by using a anti-human secreted form of ECP antibody (EG2)].
    Kobayashi H; Maeda S; Tamura M; Sakamoto S
    Nihon Rinsho; 1993 Mar; 51(3):626-30. PubMed ID: 8492435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flow cytometric analysis for the activation of peripheral immunoregulatory cells from patients with bronchial asthma].
    Aoyagi M; Shimojo N; Sato Y; Watanabe H; Sekine K; Sannomiya Y; Nishimuta T; Kohno Y; Niimi H
    Arerugi; 1997 Dec; 46(12):1243-50. PubMed ID: 9503684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins.
    Nakajima H; Loegering DA; Kita H; Kephart GM; Gleich GJ
    J Leukoc Biol; 1999 Sep; 66(3):447-54. PubMed ID: 10496315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.